Ocrelizumab gains positive CHMP opinion for RRMS and PPMS

[MSUK]

Roche, the makers of ocrelizumab have today announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for the use of ocrelizumab in adults with active relapsing remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS)...Read more - http://www.ms-uk.org/ocrelizumab-gains- ... s-and-ppms